YolTech Therapeutics

Shanghai, China · Founded 2021 · Privately Held (backing)

Developer of in vivo gene editing therapies focusing on serious diseases using lipid nanoparticle delivery systems. YolTech Therapeutics is based in Shanghai, China and was founded in 2021. Its last reported valuation was $136 million in Sep 2023. It has raised $75.1 million.

Last reported valuation

$135.8M

Oct 2026

Priced at

—

Total raised

$75.1M

Last round

—

How much has YolTech Therapeutics raised?

$75.1Macross 0 recorded rounds

Free account

More of YolTech Therapeutics with a free account

·The complete investor list: 14 names
·Watch YolTech Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

YolTech Therapeutics investors

14 investors are on record for YolTech Therapeutics, including Green Pine Capital Partners, K2VC, Unity Ventures (China) and Tianjin Venture Capital.

For fundraisers

Raising for a company like YolTech Therapeutics?

14 investors have backed YolTech Therapeutics.

See all 14 investors →

Frequently asked about YolTech Therapeutics

How much has YolTech Therapeutics raised?: YolTech Therapeutics has raised $75.1M in total across 0 recorded funding rounds.